Making any quick changes to the amount of a mind-altering substance the body receives can result in drastic side effects
Monitoring and adjustment protocols should include: Weight and vital signs at each visit (initially monthly, then quarterly) Assessment of medication tolerance and adherence Evaluation of eating behaviors and physical activity Laboratory monitoring as outlined previously Reassessment of weight-related comorbidities Realistic expectations should be established through shared decision-making
Integrated Care Approach: Patients may receive additional guidance related to sleep, nutrition, stress-modulation techniques, and lifestyle interventions that support broader neurological wellness
Given the metabolic and inflammatory components of lipedema, medications that address these pathways have generated clinical interest, including newer incretin-based therapies originally developed for type 2 diabetes and obesity management
These adjustments typically resolve within days as your body stabilizes
Cardiovasc Diabetol 21(1):169 Nauck MA, Meier JJ (2019) Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes